Haemonetics Corp
HAE· NYSE
HAEHaemonetics Corp
Filed Nov 10, 2010 · 10-Q · 39 days after period end · 0000950123-10-103691
| Metric | Q2 2010 | Q2 2009 |
|---|---|---|
| Revenue | $166.83M | $157.07M |
| Net Income | $21.34M | $18.05M |
| EPS Diluted | $0.85 | $0.69 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
ended Oct 2, 2010 · filed Nov 10, 2010 · 39 d after period end
